Neoadjuvant RC48 Plus Gemcitabine in HER2-Expressing MIBC
Clinical trial NCT07693959 · RECRUITING
Trial details
- NCT number
- NCT07693959
- Sponsor
- Zhiquan Hu
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.